Richard K. Harrison
About Richard K. Harrison
Richard K. Harrison serves as the Vice President of Biosciences at Aitia, bringing extensive experience in organizing research groups focused on Oncology, Neuroscience, and Metabolic Diseases. He has held various leadership roles in prominent organizations and has authored over 50 peer-reviewed publications.
Current Role at Aitia
Richard K. Harrison serves as the Vice President of Biosciences at Aitia, a position he has held since 2023. He works on-site in Somerville, Massachusetts. In this role, he organizes and directs research initiatives with a focus on advancing bioscience applications.
Professional Experience
Richard K. Harrison has held various significant positions throughout his career. He was the Chief Scientific Officer at Clarivate Analytics from 2010 to 2018. Prior to that, he worked as Senior Director of Biochemical and Cellular Sciences at Wyeth Pharmaceuticals from 2007 to 2010. He also served as Senior Manager at Accenture from 2018 to 2021 and Head of Research and Development at PERCAYAI for a brief period in 2021.
Education and Expertise
Richard K. Harrison earned his Ph.D. in Biochemistry from Rutgers University - Newark, where he studied from 1990 to 1994. He also holds a Master's degree in Chemistry from the same institution, completed between 1982 and 1986. His educational background supports his extensive knowledge in biochemistry, enzymology, cell biology, and biophysical chemistry.
Research and Publications
Richard K. Harrison has authored over 50 peer-reviewed publications and has delivered more than 50 invited lectures in his field. His research contributions include directing programs that have led to the development of numerous small molecule and protein therapeutic clinical candidates, as well as several marketed drugs.
Previous Employment History
Before his current role at Aitia, Richard K. Harrison worked at several notable organizations. He was a Senior Research Biochemist at Merck from 1986 to 1994, Director of High Throughput Screening at DuPont Pharmaceuticals from 1999 to 2002, and Senior Director of Biochemistry at Vitae Pharmaceuticals from 2002 to 2007. His career spans multiple sectors within the biosciences industry.